Amarin imports finished API (the actual drug) in barrels from Chemport, Nisshin and BASF all overseas. Nothing "raw" about it. They only encapsulate in the US and turn it into pills, no further manufacturing. Generics do the same thing. If the bulk API gets the tariff, everyone's in the same boat.
Market Data 
Markets 
AI
